Lack of pharmacokinetic interaction between the novel mGluR5 antagonist AFQ056 and levodopa/carbidopa in healthy volunteers

被引:0
|
作者
Chakraborty, A.
Ufer, M.
Bhad, P.
Vandemeulebroecke, M.
Gomez-Mancilla, B.
Bell, D.
Winter, S.
Woessner, R.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
456
引用
收藏
页码:S146 / S146
页数:1
相关论文
共 50 条
  • [1] AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome
    Levenga, Josien
    Hayashi, Shigemi
    de Vrij, Femke M. S.
    Koekkoek, Sebastiaan K.
    van der Linde, Herma C.
    Nieuwenhuizen, Ingeborg
    Song, Cheng
    Buijsen, Ronald A. M.
    Pop, Andreea S.
    GomezMancilla, Baltazar
    Nelson, David L.
    Willemsen, Rob
    Gasparini, Fabrizio
    Oostra, Ben A.
    NEUROBIOLOGY OF DISEASE, 2011, 42 (03) : 311 - 317
  • [2] Metabolism and Disposition of the Metabotropic Glutamate Receptor 5 Antagonist (mGluR5) Mavoglurant (AFQ056) in Healthy Subjects
    Walles, Markus
    Wolf, Thierry
    Jin, Yi
    Ritzau, Michael
    Leuthold, Luc Alexis
    Krauser, Joel
    Gschwind, Hans-Peter
    Carcache, David
    Kittelmann, Matthias
    Ocwieja, Magdalena
    Ufer, Mike
    Woessner, Ralph
    Chakraborty, Abhijit
    Swart, Piet
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (09) : 1626 - 1641
  • [3] AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization
    Vranesic, Ivo
    Ofner, Silvio
    Flor, Peter Josef
    Bilbe, Graeme
    Bouhelal, Rochdi
    Enz, Albert
    Desrayaud, Sandrine
    McAllister, Kevin
    Kuhn, Rainer
    Gasparini, Fabrizio
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) : 5790 - 5803
  • [4] The mGluR5 antagonist AFQ056 does not affect methylation and transcription of the mutant FMR1 gene in vitro
    Tabolacci, Elisabetta
    Pirozzi, Filomena
    Gomez-Mancilla, Baltazar
    Gasparini, Fabrizio
    Neri, Giovanni
    BMC MEDICAL GENETICS, 2012, 13
  • [5] Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
    Pop, Andreea S.
    Levenga, Josien
    de Esch, Celine E. F.
    Buijsen, Ronald A. M.
    Nieuwenhuizen, Ingeborg M.
    Li, Tracy
    Isaacs, Aaron
    Gasparini, Fabrizio
    Oostra, Ben A.
    Willemsen, Rob
    PSYCHOPHARMACOLOGY, 2014, 231 (06) : 1227 - 1235
  • [6] Single and multiple dose pharmacokinetics of a modified-release (MR) formulation of the mGluR5 antagonist mavoglurant (AFQ056) in healthy Japanese subjects
    Honma, W.
    Yokoi, A.
    Ufer, M.
    Desai, J.
    Kenney, C.
    Woessner, R.
    MOVEMENT DISORDERS, 2013, 28 : S162 - S162
  • [7] Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant
    Andreea S. Pop
    Josien Levenga
    Celine E. F. de Esch
    Ronald A. M. Buijsen
    Ingeborg M. Nieuwenhuizen
    Tracy Li
    Aaron Isaacs
    Fabrizio Gasparini
    Ben A. Oostra
    Rob Willemsen
    Psychopharmacology, 2014, 231 : 1227 - 1235
  • [8] mGluR5 antagonist AFQ056/Mavoglurant in Fragile X Syndrome: baseline disease severity data in adults and adolescents
    Matthisson, M.
    Angelov, A.
    Jaecklin, T.
    Koumaras, B.
    Collober, C.
    Hossain, F. N.
    Lustig, J.
    Lee, J.
    Graf, A.
    von Raison, F.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S436 - S437
  • [9] Effect of mavoglurant (AFQ056), a selective mGluR5 antagonist, on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and levonorgestrel in healthy women
    Sivasubramanian, Rama
    Chakraborty, Abhijit
    Rouzade-Dominguez, Marie-Laure
    Neelakantham, Srikanth
    Jakab, Annamaria
    Mensinga, Tjeert
    Legangneux, Eric
    Woessner, Ralph
    Ufer, Mike
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (07) : 550 - 556
  • [10] Antagonism of mGluR5 in Fragile X: A Randomized, Placebo-Controlled, Proof-of-Concept Study of AFQ056, a Novel, Sub-Type Selective mGluR5 Antagonist
    Gomez-Mancilla, Baltazar
    Jacquemont, Sebastien
    Curie, Aurore
    des Portes, Vincent
    Torrioli, Maria Giulia
    Berry-Kravis, Elizabeth
    Hagerman, Randi J.
    Ramos, Feliciano J.
    Cornish, Kim
    He, Yunsheng
    Paulding, Charles
    Neri, Giovanni
    Chen, Fei
    Hadjikhani, Nouchine
    Martinet, Danielle
    Meyer, Joanne
    Beckmann, Jacques S.
    Delange, Karine
    Brun, Amandine
    Bussy, Gerald
    Gasparini, Fabrizio
    Hilse, Talita
    Floesser, Annette
    Branson, Janice
    Bilbe, Graeme
    Johns, Donald
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 25 - 25